Pop Biotechnologies Inc.
Buffalo, NY Doing business as Pop Biotechnologies
- UEI
- ZWKMU75DGJY4
- CAGE
- 7FCR8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- Baird Research Park, 1576 Sweet Home Rd #221, Buffalo, NY 14228, USA
- Website
- pop.bio
- Founded
- 2015
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Pop Biotechnologies Inc.
Pop Biotechnologies Inc., doing business as Pop Biotechnologies, is a Buffalo, NY-based small disadvantaged business registered in the System for Award Management (SAM) that specializes in biotechnology research and development. The company focuses on developing innovative vaccine and therapeutic technologies, particularly utilizing nanoparticle and liposome-based platforms across multiple disease areas. As a for-profit organization and manufacturer of goods, Pop Biotechnologies primarily serves federal civilian agencies through research contracts and grants, with a strong emphasis on advanced biomedical research involving vaccine development, cancer therapeutics, and immunological technologies.
Through federal contract awards, Pop Biotechnologies has engaged in specialized research projects, primarily with the Department of Health and Human Services' National Institutes of Health. The company has received small business set-aside contracts focusing on developing advanced vaccine technologies, such as a $599,806 firm fixed-price contract with the National Institute of Allergy and Infectious Diseases to develop "Multivalent QS-18 Protein Nanoparticles for a Broadly Protective Influenza Virus Vaccine". These contracts are typically awarded through the Small Business Innovation Research (SBIR) program, which aims to stimulate innovation in small businesses by supporting federal research and development needs.
Pop Biotechnologies has secured numerous federal grants from agencies like the National Institute of Allergy and Infectious Diseases, the National Cancer Institute, and the National Institute on Aging. These grants support cutting-edge research in various domains, including developing vaccines for influenza, COVID-19, Candida infections, and Alzheimer's disease, as well as advanced cancer therapies like interstitial chemophototherapy. Notable grant projects include a $1,900,450 grant to develop a hexavalent adjuvanted influenza vaccine platform, a $300,000 grant for an anti-Candida peptide vaccine, and a project exploring a multivalent vaccine targeting Alzheimer's disease. The grants typically involve collaborative research with institutions like the University at Buffalo, Texas Biomedical Research Institute, and Roswell Park, demonstrating the company's commitment to innovative, interdisciplinary biomedical research.
Quick answers
What is Pop Biotechnologies Inc.'s UEI?
Pop Biotechnologies Inc.'s Unique Entity ID (UEI) in SAM.gov is ZWKMU75DGJY4.
What is Pop Biotechnologies Inc.'s CAGE code?
Pop Biotechnologies Inc.'s CAGE code is 7FCR8.
What is Pop Biotechnologies Inc.'s primary NAICS code?
Pop Biotechnologies Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Pop Biotechnologies Inc. located?
Pop Biotechnologies Inc.'s physical address in SAM.gov is Baird Research Park, 1576 Sweet Home Rd #221, Buffalo, NY 14228, USA.
Is Pop Biotechnologies Inc. registered in SAM.gov?
Yes. Pop Biotechnologies Inc.'s SAM.gov registration is active through May 18, 2027.
What is Pop Biotechnologies Inc.'s most recent federal award?
Pop Biotechnologies Inc.'s most recent federal grant award is Liposome-displayed apob fragment for active immunotherapy against atherosclerosis - project summary although… (R41HL184798), from National Heart Lung and Blood Institute, on August 1, 2026.
On GovTribe
See Pop Biotechnologies Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors